Highlights
LSE: CIR       CIR
Last Price Today's Change   Day's Range   Trading Volume
24.60   -0.45 (1.80%)  23.688 - 25.80  218,118

Overview

 
Avg Volume (4 weeks):1,153,383
4 Weeks Range:0.255 - 28.106
4 Weeks Price Volatility (%):
87.41%
52 Weeks Range:0.255 - 29.954
52 Weeks Price Volatility (%):
81.97%
Average Price Target: 327.67
Price Target Upside/Downside: +303.07

Headlines



No recent Headlines for this stock.


Business Background

Circassia Pharmaceuticals plc is a specialty biopharmaceutical company focused on allergy and respiratory diseases. The Company operates through three segments: Allergy, which relates to a range of immunotherapy development products for the treatment of allergy; NIOX, which relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO), and Respiratory, which relates to the portfolio of asthma and chronic obstructive pulmonary disease product candidates. Its next-generation immunotherapy is in Phase III testing for cat allergy. Its lead asthma treatment targets substitution of GlaxoSmithKline's (GSK's) Flixotide pMDI. It is developing therapies targeting direct substitution of Seretide pMDI and Serevent pMDI. The Company is also developing a range treatment, including a fixed dose triple combination containing an inhaled corticosteroid, long-acting beta agonist and long-acting muscarinic antagonist.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1721  2456  639  2326 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AOGL 0.015-0.001 
 CNA 36.52-2.74 
 LLOY 29.87-1.945 
 EQT 0.26+0.06 
 NGAS 0.0140.00 
 ICON 0.027+0.001 
 VAST 0.163+0.003 
 MKS 97.76-2.94 
 UJO 0.17+0.008 
 PHE 3.63+0.83 
Partners & Brokers